Artwork
iconShare
 
Manage episode 470176010 series 2902383
Content provided by Myriad Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Myriad Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Dr. Paul Sieber and co-host Ashleigh Renitsky, Oncology PA, are joined by Dr. Morris from Urology Associates of Nashville to discuss how clinical guidelines have driven increased awareness of germline and somatic mutations in prostate cancer. They discuss how germline and somatic testing can help personalize treatment strategies and share real world case studies. The conversation also encourages the need for continued education in this rapidly advancing field and adoption of genetic testing in urology.

Send us a text

  continue reading

54 episodes